{{Rsnum
|rsid=925013
|Chromosome=19
|position=50850345
|Orientation=minus
|GMAF=0.2383
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{PMID|18768516}} [[prostate cancer]] [[rs925013]]G allele was associated with higher serum PSA at diagnosis, higher percent Gleason grade 3 cancer, and lower percent high-grade and Gleason grade 4 cancer.

{{PMID Auto
|PMID=16775173
|Title=Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
}}

{{PMID Auto
|PMID=18336535
|Title=Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
}}

{{PMID Auto
|PMID=19823874
|Title=A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
|OA=1
}}

{{PMID Auto
|PMID=22901566
|Title=Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}